Concepedia

Author

Martin Stogniew

Oncoceutics (United States)

Also Known As

M Stogniew, M. Stogniew, Martin Stogniew, Martin. Stogniew, Stogniew, Martin

88

Publications

2.4K

Citations

22

H-Index

64

Concepts

All Affiliations

Oncoceutics (United States)Pfizer (United States)University of Maryland, BaltimoreMassachusetts General HospitalCornell University
MS

About

Martin Stogniew is an author at Oncoceutics (United States) specializing in medicine, pharmacology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

697

2

Engineering

2

2

28

3

Health Sciences

1

1

50

4

Natural Sciences

1

1

23

5

Social Sciences

1

1

29

Martin Stogniew

×

27

Publications

2K

Citations

21

H-Index

YearCitations

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

Jo Ishizawa, Sarah F. Zarabi, R. Eric Davis,

Cancer Cell

2019

339

A Bayesian machine learning approach for drug target identification using diverse data types

Neel S. Madhukar, Prashant K. Khade, Linda Huang,

Nature Communications

2019

247

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall,

Journal of Neuro-Oncology

2019

187

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Mark N. Stein, Joseph R. Bertino, Howard L. Kaufman,

Clinical Cancer Research

2017

153

Anidulafungin Does Not Require Dosage Adjustment in Subjects With Varying Degrees of Hepatic or Renal Impairment

James A. Dowell, Martin Stogniew, David Krause,

The Journal of Clinical Pharmacology

2007

112

Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine

James A. Dowell, Martin Stogniew, David Krause,

The Journal of Clinical Pharmacology

2005

106

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients

Isabel Arrillaga‐Romany, Yazmín Odia, Varun V. Prabhu,

Neuro-Oncology

2019

85

Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212

Jessica Wagner, C. Leah B. Kline, Marie D. Ralff,

Cell Cycle

2017

79

Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia

Takenobu Nii, Varun V. Prabhu, Vivian Ruvolo,

Leukemia

2019

77

In Vitro and In Vivo Studies To Characterize the Clearance Mechanism and Potential Cytochrome P450 Interactions of Anidulafungin

Bharat Damle, James A. Dowell, Robert L. Walsky,

Antimicrobial Agents and Chemotherapy

2008

71

Page 1